Who is sponsoring NCT05367323?

NCT05367323 is sponsored by South Valley University.

What condition does NCT05367323 study?

NCT05367323 studies Low Back Biomechanical Dysfunctions.

Is NCT05367323 still recruiting?

NCT05367323 is currently completed. Last updated 10 October 2022.

Last reviewed 2022-10-10 · How we verify

NCT05367323

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pain Pressure Threshold Values Versus the Biomechanical-Viscoelastic Findings of L4-5 Supraspinous Ligament in Women Who Underwent Cesarean Delivery With Spinal Anaesthesia

Completed Last updated 10 October 2022

What this trial tests

trial testing Pressure algometry (Baseline 2.2-Pound Dolorimeter) and Myoton PRO device (MyotonPRO; Myoton AS, Tallinn, Estonia) in Low Back Biomechanical Dysfunctions in 44 participants. Completed in 15 April 2022.

Timeline

28 June 2021

Primary endpoint
29 January 2022

15 April 2022

Quick facts

Lead sponsor	South Valley University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	44
Start date	28 June 2021
Primary completion	29 January 2022
Estimated completion	15 April 2022
Sites	1 location across Egypt

Drugs / interventions tested

Pressure algometry (Baseline 2.2-Pound Dolorimeter) and Myoton PRO device (MyotonPRO; Myoton AS, Tallinn, Estonia)

Conditions studied

Low Back Biomechanical Dysfunctions — all drugs for Low Back Biomechanical Dysfunctions →

Sponsor

South Valley University

Who can join

Adults 18 to 35, female only, with Low Back Biomechanical Dysfunctions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cesarean delivery is a major obstetric surgery that aims to save the lives of mothers and their neonates from complications that may be related to high-risk pregnancy and difficult delivery (Teguete et al., 2012). According to the updated Egyptian demographic and health survey, the rate of cesarean delivery in Egypt has increased until it reached about 52 % of all deliveries (Abdel-Tawab et al., 2018). Neuraxial anesthesia, especially spinal anaesthesia has been and continues to be the gold standard anesthesia for cesarean section (Mhyre and Sultan., 2019).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other South Valley University trials

Trials by the same sponsor.

NCT07478718 — Shoulder Exercise Training on Pain, Range of Motion, and Functional Limitations in Women Following Unilateral Mastectomy · NA · not yet recruiting
NCT07265154 — Gait Training and Artificial Intelligence · NA · recruiting
NCT07070544 — Effect of Electromagnetic Field Therapy and Customized Foot Insole on Peripheral Circulation and Ankle-Brachial Pressure · NA · not yet recruiting
NCT07128472 — Evaluation of IL 12B Genetic Polymorphism (rs3213094) · NA · recruiting
NCT06492603 — Examination of Biomechanical Characteristics of Linea Alba in Diastasis Recti Patients · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05367323 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by South Valley University
Last refreshed: 10 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05367323.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing